This is not the most recent version of the article. View current version (10 MAY 2015)

Intervention Protocol

Augmentation of psychotherapy with d-cycloserine for anxiety disorders

  1. Jonathan C Ipser1,*,
  2. Candice Sander2,
  3. Alon Seifan3,
  4. Dan J Stein4

Editorial Group: Cochrane Depression, Anxiety and Neurosis Group

Published Online: 15 APR 2009

Assessed as up-to-date: 2 FEB 2009

DOI: 10.1002/14651858.CD007803


How to Cite

Ipser JC, Sander C, Seifan A, Stein DJ. Augmentation of psychotherapy with d-cycloserine for anxiety disorders (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 2. Art. No.: CD007803. DOI: 10.1002/14651858.CD007803.

Author Information

  1. 1

    University of Stellenbosch, MRC Research Unit for Anxiety and Stress Disorders, Tygerberg, Western Cape, South Africa

  2. 2

    Die Wilgers, Pretoria, South Africa

  3. 3

    Mount Sinai School of Medicine, New York, USA

  4. 4

    University of Cape Town, Department of Psychiatry and Mental Health, Cape Town, South Africa

*Jonathan C Ipser, MRC Research Unit for Anxiety and Stress Disorders, University of Stellenbosch, PO Box 19063, Tygerberg, Western Cape, 7505, South Africa. jonathan.ipser@uct.ac.za. jonathanipser@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 15 APR 2009

SEARCH

This is not the most recent version of the article. View current version (10 MAY 2015)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

1) To provide an estimate of the overall effects of d-cycloserine in improving treatment response and reducing symptom severity in anxiety disorders treated with psychotherapy.

2) To determine whether the efficacy and tolerability of d-cycloserine is specific to particular anxiety disorders.

3) To identify which factors (clinical, methodological) predict response to pharmacotherapy.